73. Who Pays for Multimillion-Dollar Miracle Cures?

73. Who Pays for Multimillion-Dollar Miracle ...

Up next

The Economics of Everyday Things: Animal Urine

In the newest show from the Freakonomics Radio Network, host Zachary Crockett explores the hidden side of the things around us. This week: One creature’s trash is another’s cash. (Or, how one man found profit in pee.) Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com ...  Show more

Tom Brady, A.D.H.D., and a Really Bad Headache (Bonus)

A sneak peek at Bapu's new book, Random Acts of Medicine, available now from Doubleday, and an announcement about the show. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising. 

Recommended Episodes

a16z Podcast: The Economics of Expensive Medicines
The a16z Show

with Andrew Lo (@AndrewWLo) and Jorge Conde (@JorgeCondeBio)

The advent of new gene and cell therapies are beginning to approach that holy grail of medicine—that of a possible cure. But they are also more expensive than any medicines ever sold before. In this episode, M ...

  Show more

Human Genome Editing - Promise and Peril
Science In Action

Human Genome Editing: The team meet experts at the Human Genome Editing Summit in London, seeking to cure genetic disease and ensure that it's safe and available to all. Roland Pease hears from Victoria Gray, the first person to be cured of the debilitating and life-shortening di ...  Show more

Episode 54: Can AI Transform Drug Development? With Dr Scott Chetham, CEO of Faro Health
The Medical AI Podcast

It’s widely assumed that drug treatment is a miracle of modern science. However, it’s equally arguable that modern drug treatment is a very expensive disaster, with serious consequences for public health. For example, a drug typically takes 10-12 years to develop and the cost is ...  Show more

Special Encore: U.S. Pharmaceuticals - The Future of Genetic Medicine
Thoughts on the Market

Original Release on February 6th, 2023: As new gene therapies are researched, developed and begin clinical trials, what hurdles must genetic medicine overcome before these therapies are commonly available? Head of U.S. Pharmaceuticals Terence Flynn and Head of U.S. Biotech Mat ...

  Show more